Helmy Eltoukhy is the Co-Chief Executive Officer of Guardant Health, where he has been a key leader since co-founding the company in 2013. His background is in biotechnology, and he earned a Ph.D. in Bioengineering from Stanford University. Before starting...
Helmy Eltoukhy is the Co-Chief Executive Officer of Guardant Health, where he has been a key leader since co-founding the company in 2013. His background is in biotechnology, and he earned a Ph.D. in Bioengineering from Stanford University. Before starting Guardant Health, Helmy worked at Illumina, a major player in genetic analysis. He played a significant role in developing innovative technologies for genetic sequencing, which helps improve cancer detection and treatment. He also co-founded Avantome, a company focused on semiconductor sequencing, which was later acquired by Illumina. In 2021, he was appointed Chairperson of the Board at Guardant Health, marking a new chapter in his career while continuing to lead the company's oncology division. Interestingly, Helmy waived his salary and bonuses for seven years to align his interests with the company's performance and focus on long-term growth. This commitment shows his dedication and belief in what Guardant Health is doing to change lives through advanced cancer diagnostics.